A
Abeona Therapeutics
New York, United States
Founded 1974 NASDAQ: ABEO
About
Clinical-stage biopharmaceutical company developing gene therapies for rare diseases
Company Details
- Type
- public
- Employees
- 100+
- Funding
- Public
Key Products
- Pz-cel
- EB-101
- ABO-102